BOOT enters its July 31 earnings print with a meaningful divergence taking shape: short sellers have been cutting exposure all month while options traders shifted toward more defensive positioning this week — an unusual split heading into a catalyst event.
The short-side retreat is the clearest story in the data. Short interest has fallen 17.6% over the past month to roughly 8.6% of the free float, with the bulk of that covering happening in mid-July, when positions dropped from around 3.4 million shares to just under 2.8 million. The past week alone saw a 7.6% reduction. That's a meaningful move for a name where shorts had been building through June. Borrow conditions confirm there's no pressure forcing the exits — cost to borrow remains low at 0.47%, barely changed over 30 days, and availability is very loose at 710%, well above the 52-week floor of 465%. Shorts are covering by choice, not because they're getting squeezed.
Options positioning tells a more cautious story this week. The put/call ratio eased back to 0.58 on Tuesday, but context matters: the reading spent most of the past two weeks between 0.71 and 0.88, well above its 20-day average of 0.37, after a month-long stretch where it ran closer to 0.17. That sharp shift in hedging demand — from almost entirely call-heavy to much more balanced — coincides exactly with the July 17 period when PCR jumped from 0.18 to 0.78 in a single session. The pattern suggests options traders rerated their pre-earnings hedging needs sharply mid-month, and haven't fully backed off despite the stock's 6.4% gain this week to $158.62. Given the 52-week PCR high of 1.14, positioning isn't extreme, but the jump is notable.
The Street remains broadly constructive, though targets have drifted lower since the last print. The consensus mean target of $224.79 implies roughly 42% upside from current levels. BTIG reiterated a Buy with a $235 target as recently as July 27 — the day before the data snapshot — the clearest pre-earnings signal of conviction from a named firm. After the May earnings report, several analysts trimmed targets modestly while keeping positive ratings: BofA cut to $206, Baird to $225, Piper Sandler to $226. UBS moved in the other direction, raising to $272. The bull case centers on margin expansion through AI-assisted design, factory-direct sourcing, and exclusive brand growth. Bears point to gross margin pressure — a 20 basis-point contraction flagged for the current fiscal year — and valuation concerns. The P/E sits at roughly 17x and EV/EBITDA near 11.3x, both having drifted up slightly over the past week alongside the stock's recovery. The short score of 50.3 ranks in the 27th percentile, reflecting the recent short-covering trend.
The last earnings reaction provides a reference point. After the May print, the stock fell less than 1% on the day but recovered to gain 6.4% over the following five sessions — a pattern suggesting the market absorbed guidance cautiously before re-engaging on the upside. The question heading into July 31 is whether that dynamic repeats, particularly given that shorts have already cut exposure and analysts have already reset their models to the new cost-structure reality.
With the print due after Thursday's close, the setup worth watching is whether the short-covering of the past month reflects insider knowledge of strong results, or simply pre-earnings de-risking that could reverse if the margin trajectory disappoints.
See the live data behind this article on ORTEX.
Open BOOT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
